Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
7 drugs in development
By Therapeutic Area
top 6
R&D Momentum
87/100
Pipeline Velocity
65/100
Trial Completion Rate
71/100
Pipeline Concentration
16/100
Pipeline Freshness
59/100
Strategic Signals
Activity
Last 14 days
ACCESS: AI-Driven Consent Simplification Study
Quantitative Assessment of Pelvic Floor Muscle Fitness in Myofascial Pelvic Pain
A Randomized, Double-blind, Dose-escalation, Sham-controlled Trial to Evaluate the Safety and Feasibility of Extracorporeal Shockwave Therapy (ESWT) for the Management of Stress Fractures and High-grade Bone Stress Injuries (BSIs)
Autism Research Consortium on Physical Health: A Two-Part Intervention to Target Cardiovascular Health
Sinus Disease in Young Children With Cystic Fibrosis
Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange
The Impact of Sinus Surgery in the Era of Highly Effective Modulatory Therapy
Telerehabilitation In The Home After Stroke: A Randomized, Controlled, Assessor-Blind Clinical Trial
Effectiveness of Evidence-Based Mental Health Practices for Youth With Autism Supported by Online Consultation to Practitioners in Community and Navy Clinics
City of Pomona's Guaranteed Income Program for Parents With Children Under the Age of Five
The Effect of Daily Mixed Spice Consumption and Protein Supplementation on Muscle Mass and Function in Adults Using GLP-1 Agonists for Weight Management: A Pilot Study
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)